Skip to content
Use caution Medical device recall · FDA · Published April 2, 2018

Zimmer Biomet Hip System Recall: Risk of Wrong Size Head Causing Dislocation

Zimmer Biomet recalls hip implants with potentially mixed head sizes, risking dislocation during surgery. Affected patients should contact the company for details.

🇺🇸 FDA recall #Z-1537-2018Medical deviceZimmer Biomet ›
Take action

Contact the company

Recalling firmZimmer Biomet, Inc.56 E Bell Dr · Warsaw, IN 46582-6989
✎ GovInfoNow plain-language explainer

Zimmer Biomet is recalling hip implants that could have mixed head sizes, which might cause dislocation during surgery. This could delay procedures or lead to complications if the wrong size head is used. Read more at govinfonow.com/recall/71557-zimmer-biomet-hip-system-recall-risk-of-wrong-size-head.

Source Summary by GovInfoNow · govinfonow.com/recall/71557-zimmer-biomet-hip-system-recall-risk-of-wrong-size-head · Updated August 21, 2026 · FDA enforcement record: FDA #Z-1537-2018

Cite this page

“Zimmer Biomet Hip System Recall: Risk of Wrong Size Head Causing Dislocation.” GovInfoNow, updated August 21, 2026. https://govinfonow.com/recall/71557-zimmer-biomet-hip-system-recall-risk-of-wrong-size-head. Based on FDA recall #Z-1537-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1537-2018%22&limit=1).

The FDA announced on April 2, 2018, that Zimmer Biomet, Inc. voluntarily recalled two lots of modular heads for the Biomet Hip System due to potential commingling. This error risks surgery delays and dislocation from incorrect sizing. The agency issued recall number Z-1537-2018.

How to tell if you have it

  • Brand: Zimmer Biomet
  • Product: Modular Head Component, Biomet Hip System; Item No. 163669, Hip Joint, metal/polymer semi-constrained cemented prosthesis
  • Lot code: 276760
  • Units affected: 30

The hazard

Two lots of different sized modular heads were potentially commingled. The FDA stated this risks delay in surgery and dislocation due to the use of an incorrect sized head.

Context

GovInfoNow's records show Zimmer Biomet, Inc. has had 94 other recalls since June 5, 2017. Recent similar product recalls include the Zimmer Affixus Femoral Nails Recall (Dec. 2, 2025) and the Zimmer Persona Revision Femoral Distal Augment Recall (May 11, 2026). Other brand recalls involve a Spinal Rod Cutter fracture risk (Nov. 20, 2020), a Polaris 5.5 Spinal System screw failure risk (Nov. 17, 2020), and unconfirmed sterilant risks in hip cup components (Sept. 24, 2020).

How to tell if you have this one

Check for the lot number 276760 on the implant packaging or documentation. The product is a hip joint component made by Zimmer Biomet.

  • Brand
    Zimmer Biomet
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Worldwide Distribution: US (nationwide) in states of: AL, AR, FL, GA, IN, KY, LA, MO, MS, OH, OK, TX, and VA; and countries of: Canada, Costa Rica and Chile.
Recall numberProduct, codes & lotsQuantity
Z-1537-2018Modular Head Component, Biomet Hip System; Item No. 163669, Hip Joint, metal/polymer semi-constrained cemented prosthesis The device is used in treatment of patients who need total hip arthroplasty, and consists of modular components and corresponding instruments.; lot 27676030
Z-1538-2018Modular Head Component, Biomet Hip System; Item No. 11-363661, Hip Joint, metal/polymer/metal, semi-constrained, porous-coated, uncemented prosthesis The device is used in treatment of patients who need total hip arthroplasty, and consists of modular components and corresponding instruments.; lot 29934018
Based on the official FDA remedy

What to do — step by step

  1. Check Your Implant Lot Number

    Look for the lot number 276760 on the implant packaging or documentation to confirm if it's affected.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 13 states.

Alaska: nationwideAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: nationwideWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: nationwideMNIllinois: nationwideILWisconsin: nationwideWIMichigan: nationwideMINew York: nationwideNYRhode Island: nationwideRIMassachusetts: nationwideMAOregon: nationwideORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: nationwidePANew Jersey: nationwideNJConnecticut: nationwideCTCalifornia: nationwideCAUtah: nationwideUTColorado: nationwideCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: nationwideWVVirginia: named in the noticeVAMaryland: nationwideMDDelaware: nationwideDEArizona: nationwideAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: named in the noticeARTennessee: nationwideTNNorth Carolina: nationwideNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: nationwideHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide Distribution: US (nationwide) in states of: AL, AR, FL, GA, IN, KY, LA, MO, MS, OH, OK, TX, and VA; and countries of: Canada, Costa Rica and Chile.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Arkansas, Florida, Georgia, Indiana, Kentucky, Louisiana, Mississippi, Missouri, Ohio, Oklahoma, Texas, Virginia.

Recall timeline

FDA terminated this recall 2.1 years after the firm started it.

1. Firm started the recall: Apr 2, 201812. FDA classified it Class II: Apr 27, 201823. Published in FDA’s Enforcement Report: May 9, 201834. FDA terminated the recall: May 12, 2020420182020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is there a risk of serious injury from this recall?

The recall risks dislocation and surgery delays, but the hazard does not cause immediate serious injury in normal use.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1537-2018 (April 2, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1537-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on August 21, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA